NanoFuse Biologics
acquired by KICMalden, US · Founded 2018 · 1 known investors
US-based vertically integrated biologics and disc replacement manufacturer, acquired by KIC in 2018.
Founders & leadership
Board
AH
Aditya HumadCFO of Manager
Investors · 1
Reported raises · per SEC filings
Form D private placements$50K disclosed across 1 round · 2018
▶$50KraisedJun 2018 · 1 investors · BiotechnologyRule 506(c)
▶$50KraisedJun 2018 · 1 investors · Biotechnology
Rule 506(c)Officers, directors & promoters on the filing
- Aditya HumadExecutive Officer
- Offering amount
- $2M
- Amount sold
- $50K
- Minimum investment
- $50K
- Proceeds to insiders
- $25K
- First sale
- May 2018
- Incorporated
- Limited Liability Company, Delaware, 2018
- Federal exemptions
- 06c
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 1
by search overlap
Companies competing with NanoFuse Biologics for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does NanoFuse Biologics do?
- US-based vertically integrated biologics and disc replacement manufacturer, acquired by KIC in 2018.
- Who are NanoFuse Biologics's investors?
- NanoFuse Biologics's investors include KIC Ventures.
- How much funding has NanoFuse Biologics raised?
- NanoFuse Biologics has disclosed $50K raised across 1 round.
- Who acquired NanoFuse Biologics?
- NanoFuse Biologics was acquired by KIC.
- Where is NanoFuse Biologics headquartered?
- NanoFuse Biologics is headquartered in Malden, US.